Making a Case for Defining Osteonecrosis of the Jaw

Por Van Poznak, C.
Publicado em 2011

Self-reported Oral Health and Quality of Life of Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors and Women without Cancer Diagnoses: A Longitudinal Analysis

Por Taichman, L. Susan, Van Poznak, C, Inglehart, Marita R.
Publicado no Support Care Cancer (2016)

Periodontal Health in Women with Early Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study

Por Taichman, LS, Inglehart, MR, Giannobile, W, Braun, T, Kolenic, G, Van Poznak, C
Publicado no J Periodontol (2015)

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours

Por Van Poznak, C, Cross, S S, Saggese, M, Hudis, C, Panageas, K S, Norton, L, Coleman, R E, Holen, I
Publicado em 2006

Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis

Por Messer, J.G., Mendieta Calle, J.L., Jiron, J.M., Castillo, E.J., Van Poznak, C., Bhattacharyya, N., Kimmel, D.B., Aguirre, J.I.
Publicado no Bone (2017)

Cancer-associated bone disease

Por Rizzoli, R., Body, J.-J., Brandi, M.-L., Cannata-Andia, J., Chappard, D., El Maghraoui, A., Glüer, C.C., Kendler, D., Napoli, N., Papaioannou, A., Pierroz, D.D., Rahme, M., Van Poznak, C.H., de Villiers, T.J., El Hajj Fuleihan, G.
Publicado no Osteoporos Int (2013)